Table 4.
Acromegaly Patient Cohort n=26.
| Age (years) | Mean | SD |
|---|---|---|
| 49.3 | 15.5 | |
| Tumor size (mm) | Mean | SD |
| 17.8 | 9.7 | |
| Gender | N | Percent |
| F | 11 | 42% |
| M | 15 | 58% |
| Medial walls resected | N | Percent |
| 21/26 | 81% | |
| IGF-1 levels | Mean | SD |
| Preoperative | 701.5 | 201.9 |
| Postoperative | 194.6 | 54.7 |
| Growth hormone levels | Mean | SD |
| Postoperative | 0.96 | 0.8 |
| WHO 2017 adenoma classification | N | Percent |
| Densely granulated | 4 | 16% |
| Sparsely granulated | 10 | 42% |
| Mixed somatolactotroph | 7 | 23% |
| Mammosomatotroph | 2 | 6% |
| Plurihormonal | 3 | 12% |
| Knosp grade | N | Percent |
| Grade 0 | 6 | 23% |
| Grade 1 | 12 | 46% |
| Grade 2 | 4 | 15% |
| Grade 3A | 0 | 0% |
| Grade 3B | 2 | 8% |
| Grade 4 | 2 | 8% |
| Remission rates | N | Percent |
| Biochemical remission (Surgery) | 23/25 | 92% |
| Biochemical remission (Surgery + Adjuvant) | 2/25 | 8% |
| Biochemical remission of entire case series | 25/25 | 100% |
Cohort of 26 consecutive newly diagnosed acromegaly patients. Variables include age, tumor size, gender, initial presentation, number of medial walls resected, postoperative growth hormone levels, preoperative and postoperative IGF-1 levels, WHO 2017 Adenoma subtype classification, Knosp grade and remission rates. Categorical variables are reported as number and percentage, and continuous variables are reported as mean ± standard deviation.